Professor Dr. said. Stanford: “There is no doubt that people who received the J&J vaccine were less protected from disease than those who received two doses of other vaccines.” Michael Lynn.
Jason Gallagher, an infectious disease expert at Temple University’s School of Pharmacy, recently received a dose of Biontech/Pfizer at the Philadelphia Immunization Clinic, where he was vaccinating himself. He got the J&J vaccine in a clinical trial in November.
He was concerned about data from the UK showing lower efficacy against the delta variant in people who received only one dose of the vaccine.
Well-known scientist Angela Rasmussen, a researcher with the University of Saskatchewan Vaccines and Infectious Diseases Organization, said on Twitter that she received a dose of the vaccine from Biontech/Pfizer after receiving it from J&J in April.
Rasmussen encouraged patients to talk to their doctors about a booster dose, but she wanted to Reuters Not expressing an opinion.
Boosting with a second dose of J&J or one of the mRNA vaccines could provide broader protection, “but we need CDC-FDA data and guidance,” Vaccine expert Peter Hotez of Baylor College of Medicine said in a tweet.

Sylvia Plath writes for Social Post News, covering news, politics, business, technology, sport, entertainment, and lifestyle. She focuses on clear, reliable reporting and useful information, helping readers stay informed about current events, emerging trends, and stories that matter.

More Stories
Bumblebees Show Problem-Solving Skills Once Thought Limited to Larger-Brained Animals
Artemis 2’s Orion Heat Shield Faces Critical Test as Astronauts Prepare for Fiery Earth Reentry
Coral Seeding: Artificial Insemination Makes Coral More Heat Tolerant